Everest Group
EG NYSE Reinsurance Financials FY2016βFY2025
Everest Group's revenue rose 1.2% to $17.5 billion in fiscal 2025. Its net margin was 9.1%, up from 8.0% a year earlier. It paid out $1.1 billion in dividends and buybacks. The diluted share count fell 2.6%.
About these figures. Everest tags its senior notes and its long-term subordinated notes separately, with no total in the SEC's structured data, so debt and debt-based ratios are left blank. Everest's cash flow statement doesn't show its spending on property and equipment as a line of its own, so capital spending and free cash flow are left blank.
What Everest Group does
No business description yet.
- Legal name
- EVEREST GROUP, LTD.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001095073-26-000006
0001095073
Revenue and margins
Everest Group had $17.5B of revenue in fiscal 2025, up 1.2% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 5.3% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β in fiscal 2025, β of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Everest Group returned $1.1B to shareholders in fiscal 2025. The diluted share count fell 2.6%.
Value Everest Group yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β and divides by 41.6M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 8.4x Β· peers 10.3x Β· sector 13.7x.
Balance sheet
Cash, debt and the ratios that show how comfortably Everest Group can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $1.4B | $1.4B | $1.4B | $1.9B | $4.3B |
| Interest coverage | 25.9x | 7.0x | 17.6x | 11.2x | 13.6x |
| Total assets | $38.2B | $40.0B | $49.4B | $56.3B | $62.5B |
| Total liabilities | $28.0B | $31.5B | $36.2B | $42.5B | $47.1B |
| Shareholders' equity | $10.1B | $8.4B | $13.2B | $13.9B | $15.5B |
| Net debt (β = net cash) | β | β | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$4.4M
2 insiders
Sold, 12 months
$0.3M
1 insider
Of sales under plans
0%
$0.0M
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | β / 9 | β / 9 | β / 9 |
| Accruals ratio | β4.6% | β6.8% | β2.5% |
| Altman Z'' | β | β | β |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Everest Group EG | $15.5B | 1.2% | β | β | β | 8.4x | β | |
| Reinsurance Group of America RGA | $17.4B | 7.2% | β | β | β | 11.6x | β | Compare β |
| RenaissanceRe RNR | $14.6B | 9.9% | β | β | 54.2% | 6.3x | β | Compare β |
| MGIC Investment MTG | $6.1B | 0.5% | β | 70.2% | β | 9.0x | β | Compare β |
| Aon AON | $64.9B | 9.5% | 25.3% | 18.7% | 15.6% | 16.7x | 4 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $5.8B | $6.6B | $7.4B | $8.2B | $9.6B | $11.9B | $12.1B | $14.6B | $17.3B | $17.5B |
| Interest expense | $36.2M | $31.6M | $31.0M | $31.7M | $28.0M | $62.0M | $98.0M | $130M | $147M | $150M |
| Pretax income | $1.1B | $419M | β$242M | $1.1B | $585M | $1.5B | $588M | $2.2B | $1.5B | $1.9B |
| Income tax | $104M | β$63.3M | β$331M | $89.5M | $71.0M | $167M | β$9.0M | β$363M | $120M | $296M |
| Net income | $996M | $483M | $89.0M | $1.0B | $514M | $1.4B | $597M | $2.5B | $1.4B | $1.6B |
| Diluted EPS | $23.68 | $11.70 | $2.17 | $24.70 | $12.78 | $34.62 | $15.19 | $60.19 | $31.78 | $37.80 |
| Diluted shares | 0.04B | 0.04B | 0.04B | 0.04B | 0.04B | 0.04B | 0.04B | 0.04B | 0.04B | 0.04B |
| Cash flow | ||||||||||
| Cash from operations | $1.4B | $1.2B | $610M | $1.9B | $2.9B | $3.8B | $3.7B | $4.6B | $5.0B | $3.1B |
| Stock-based compensation | $26.4M | $30.3M | $32.4M | $34.0M | $39.0M | $43.0M | $45.0M | $49.0M | $63.0M | $61.0M |
| Acquisitions | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Share buybacks | $386M | $50.0M | $75.3M | $24.6M | $200M | $225M | $61.0M | $0.0M | $200M | $797M |
| Dividends paid | $195M | $207M | $216M | $234M | $249M | $247M | $255M | $288M | $334M | $335M |
| Dividends and buybacks | $582M | $257M | $292M | $259M | $449M | $472M | $316M | $288M | $534M | $1.1B |
| Balance sheet | ||||||||||
| Cash and short-term investments | $486M | $636M | $659M | $810M | $803M | $1.4B | $1.4B | $1.4B | $1.9B | $4.3B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Inventory | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Total assets | $21.3B | $23.6B | $24.8B | $27.3B | $32.7B | $38.2B | $40.0B | $49.4B | $56.3B | $62.5B |
| Total liabilities | $13.2B | $15.2B | $16.9B | $18.2B | $23.0B | $28.0B | $31.5B | $36.2B | $42.5B | $47.1B |
| Shareholders' equity | $8.1B | $8.3B | $7.9B | $9.1B | $9.7B | $10.1B | $8.4B | $13.2B | $13.9B | $15.5B |
| Margins | ||||||||||
| Net margin | 17.2% | 7.3% | 1.2% | 12.3% | 5.4% | 11.6% | 5.0% | 17.3% | 8.0% | 9.1% |
| Returns | ||||||||||
| Return on equity | 12.7% | 5.9% | 1.1% | 11.9% | 5.5% | 13.9% | 6.4% | 23.3% | 10.1% | 10.9% |
| Return on assets | 4.8% | 2.2% | 0.4% | 3.9% | 1.7% | 3.9% | 1.5% | 5.6% | 2.6% | 2.7% |
| Growth | ||||||||||
| Revenue growth | 2.1% | 14.3% | 11.2% | 11.8% | 16.6% | 23.6% | 1.6% | 21.0% | 18.5% | 1.2% |
| Net income growth | 1.9% | β51.6% | β81.6% | 1,033.7% | β49.1% | 168.3% | β56.7% | 321.6% | β45.5% | 15.9% |
| EPS growth | 7.2% | β50.6% | β81.5% | 1,038.3% | β48.3% | 170.9% | β56.1% | 296.3% | β47.2% | 18.9% |
| Share count change | β5.0% | β1.9% | β0.6% | β0.4% | β1.0% | β1.8% | β1.3% | 6.4% | 3.4% | β2.6% |
| Financial health | ||||||||||
| Interest coverage | 31.4x | 14.3x | β6.8x | 35.7x | 21.9x | 25.9x | 7.0x | 17.6x | 11.2x | 13.6x |
| Capital allocation | ||||||||||
| Stock comp / revenue | 0.5% | 0.5% | 0.4% | 0.4% | 0.4% | 0.4% | 0.4% | 0.3% | 0.4% | 0.4% |
| Quality scores | ||||||||||
| Accruals ratio | β1.9% | β3.0% | β2.2% | β3.2% | β7.9% | β6.9% | β7.9% | β4.6% | β6.8% | β2.5% |
Source: SEC EDGAR XBRL filings (CIK 0001095073). Data updated October 9, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.